Activation of TRPV2 and BKCa channels by the LL-37 enantiomers stimulates calcium entry and migration of cancer cells

Oncotarget - Tập 7 Số 17 - Trang 23785-23800 - 2016
Audrey Gambade1, Sami Zreika2, Maxime Guéguinou1,3, Igor Chourpa4, Gaëlle Fromont5,1,3, Ana María Bouchet1,3, Julien Burlaud‐Gaillard4, Marie Potier‐Cartereau1,3, Sébastien Roger1, Vincent Aucagne6, Stéphan Chevalier1, Christophe Vandier1,3, Caroline Goupille5,1, Günther Weber1,4
1Inserm, UMR1069, Nutrition, Croissance et Cancer, Tours, France
2Department of Medical Lab Technology, Jinan University, Tripoli, Lebanon
3Ion channel network Canceropole Grand Ouest
4Université François Rabelais, Tours, France
5CHRU Hôpital Bretonneau, Tours, France
6Centre de Biophysique Moléculaire, CNRS UPR 4301, Orléans, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Schoofs, 2012, A comprehensive summary of LL-37, the factoctum human cathelicidin peptide, Cell Immunol, 280, 22, 10.1016/j.cellimm.2012.11.009

Stahle, 2005, Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells, Int J Cancer, 114, 713, 10.1002/ijc.20795

Stahle, 2009, Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer, Breast Cancer Res, 11, R6, 10.1186/bcr2221

Scandurro, 2009, Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells, Mol Cancer Res, 7, 907, 10.1158/1541-7786.MCR-08-0326

Kleeff, 2015, Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment, Gut, 64, 1921, 10.1136/gutjnl-2014-308935

Bals, 2008, The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells, Lung Cancer, 59, 12, 10.1016/j.lungcan.2007.07.014

Ponnazhagan, 2011, LL-37 as a therapeutic target for late stage prostate cancer, Prostate, 71, 659, 10.1002/pros.21282

Scandurro, 2008, Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion, Int J Cancer, 122, 1030, 10.1002/ijc.23186

Stahle, 2012, Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor, Oncogene, 31, 352, 10.1038/onc.2011.239

Monteith, 2015, Altered calcium signaling in cancer cells, Biochim Biophys Acta, 1848, 2502, 10.1016/j.bbamem.2014.08.016

Constantin, 2015, Plasma membrane calcium channels in cancer: Alterations and consequences for cell proliferation and migration, Biochim Biophys Acta, 1848, 2512, 10.1016/j.bbamem.2015.06.009

Shuba, 2011, Calcium in tumour metastasis: new roles for known actors, Nat Rev Cancer, 11, 609, 10.1038/nrc3105

Jiang, 2015, Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives, Biochim Biophys Acta, 1848, 2584, 10.1016/j.bbamem.2014.10.029

Vandier, 2015, Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids?, Biochim Biophys Acta, 1848, 2603, 10.1016/j.bbamem.2014.10.036

Dryer, 2009, Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes, Mol Pharmacol, 75, 466, 10.1124/mol.108.051912

Ouadid-Ahidouch, 2012, Human ether a-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry, J Cell Physiol, 227, 3837, 10.1002/jcp.24095

Jaffres, 2013, Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases, Cancer Res, 73, 4852, 10.1158/0008-5472.CAN-12-4572

Ali, 2011, Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization, J Biol Chem, 286, 44739, 10.1074/jbc.M111.277152

Dehaye, 2006, Modulation by LL-37 of the responses of salivary glands to purinergic agonists, Mol Pharmacol, 69, 2037, 10.1124/mol.105.021444

Zanetti, 2008, The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner, J Biol Chem, 283, 30471, 10.1074/jbc.M802185200

Lakowicz, 2006, Principles of Fluorescence Spectroscopy (3rd) Third Edition, Springer

Helmreich, 2003, Environmental influences on signal transduction through membranes: a retrospective mini-review, Biophys Chem, 100, 519, 10.1016/S0301-4622(02)00303-4

Holowka, 2007, Lipid rafts, fluid/fluid phase separation, and their relevance to plasma membrane structure and function, Semin Cell Dev Biol, 18, 583, 10.1016/j.semcdb.2007.07.010

Gratton, 1990, Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence, Biophys J, 57, 1179, 10.1016/S0006-3495(90)82637-0

Gratton, 1991, Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence, Biophys J, 60, 179, 10.1016/S0006-3495(91)82041-0

Gross, 1984, Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds, Circ Res, 55, 585, 10.1161/01.RES.55.5.585

Huarte, 2015, Two-photon Laurdan studies of the ternary lipid mixture DOPC:SM:cholesterol reveal a single liquid phase at sphingomyelin:cholesterol ratios lower than 1, Langmuir, 31, 2808, 10.1021/la504251u

Roger, 2011, P2X receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness, Oncogene, 30, 2108, 10.1038/onc.2010.593

Roger, 2013, Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors, Carcinogenesis, 34, 1487, 10.1093/carcin/bgt099

Kojima, 2007, Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages, J Cell Physiol, 210, 692, 10.1002/jcp.20883

Kojima, 1999, Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I, Nat Cell Biol, 1, 165, 10.1038/11086

Rassendren, 2006, PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane, Cell Calcium, 39, 495, 10.1016/j.ceca.2006.01.009

Potier-Cartereau, 2014, KCa and Ca channels: The complex thought, Biochim Biophys Acta, 1843, 2322, 10.1016/j.bbamcr.2014.02.019

Besson, 2004, Description and role in proliferation of iberiotoxin-sensitive currents in different human mammary epithelial normal and cancerous cells, Biochim Biophys Acta, 1667, 190, 10.1016/j.bbamem.2004.10.002

Ando, 2015, Vascular endothelial cell membranes differentiate between stretch and shear stress through transitions in their lipid phases, Am J Physiol Heart Circ Physiol, 309, H1178, 10.1152/ajpheart.00241.2015

Bonavida, 2007, Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications, Adv Cancer Res, 98, 149, 10.1016/S0065-230X(06)98005-1

Theret, 2015, Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility, Oncogene, 34, 996, 10.1038/onc.2014.55

Chang, 2016, Candidate anti-metastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity, Cancer Res

Gratton, 2013, Laurdan fluorescence lifetime discriminates cholesterol content from changes in fluidity in living cell membranes, Biophys J, 104, 1238, 10.1016/j.bpj.2012.12.057

Nagaoka, 2016, Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation, J Immunol, 196, 1338, 10.4049/jimmunol.1403203

Ramamoorthy, 2003, Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37, Biochemistry, 42, 6545, 10.1021/bi0273563

Veglia, 2008, NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles, Biochemistry, 47, 5565, 10.1021/bi702036s

Ramamoorthy, 2004, Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37, Biochemistry, 43, 8459, 10.1021/bi036284s

Imaizumi, 2003, TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes, Circ Res, 93, 829, 10.1161/01.RES.0000097263.10220.0C

Shigekawa, 2003, A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel, J Cell Biol, 161, 957, 10.1083/jcb.200301101

Kojima, 2015, Translocation of TRPV2 channel induced by focal administration of mechanical stress, Physiol Rep, 3

Bergerat, 2010, Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance, Cancer Res, 70, 1225, 10.1158/0008-5472.CAN-09-2205

Zhao, 2014, Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma, Med Oncol, 31, 17, 10.1007/s12032-014-0017-5

Ouadid-Ahidouch, 2011, High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters, Cell Physiol Biochem, 28, 813, 10.1159/000335795

Pfosser, 2003, An angiogenic role for the human peptide antibiotic LL-37/hCAP-18, J Clin Invest, 111, 1665, 10.1172/JCI17545

Perrier, 2011, Modular design for the controlled production of polymeric nanotubes from polymer/peptide conjugates, Polym Chem, 2, 1956, 10.1039/c1py00202c

Chourpa, 2011, Doxorubicin delivered to MCF-7 cancer cells by superparamegnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity, J Nanopart Res, 13, 959, 10.1007/s11051-010-0093-1

Tokuyasu, 1973, A technique for ultracryotomy of cell suspensions and tissues, J Cell Biol, 57, 551, 10.1083/jcb.57.2.551